Guardant Health, INC Form 4 insider transactions

John G. Saia, Chief Legal Officer of Guardant Health, Inc., reports the acquisition of stock options and restricted stock units.

Chief People Officer Terilyn J. Monroe of Guardant Health, Inc. reports the acquisition of stock options and restricted stock units.

Chief Information Officer Kumud Kalia reports the acquisition of stock options and restricted stock units in Guardant Health, Inc.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the acquisition of stock options and restricted stock units.

Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc., reports the acquisition of restricted stock units on March 12, 2025.

Craig Eagle, Chief Medical Officer of Guardant Health, reports the acquisition of stock options and restricted stock units.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the acquisition of stock options and restricted stock units.

Michael Brian Bell, CFO of Guardant Health, reports the acquisition of stock options and restricted stock units.

Director Meghan Joyce reported the sale of 100 shares of Guardant Health common stock at $42.71 and the exercise of options for 67 shares.

John G. Saia, Chief Legal Officer of Guardant Health, Inc., reports transactions involving common stock and restricted stock units.

Chief People Officer Terilyn J. Monroe reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to her beneficial ownership of Guardant Health stock.

Kumud Kalia, Chief Information Officer of Guardant Health, reports stock transactions including acquisition and disposal of common stock and vesting of restricted stock units.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting of performance-based restricted stock units and associated tax withholding.

Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.

Michael Brian Bell, CFO of Guardant Health, reports the vesting of performance-based restricted stock units and subsequent tax withholding.

Director Steve Krognes reports the vesting and acquisition of 154 shares of Guardant Health common stock from restricted stock units on February 28, 2025.

Director Tariq Musa sold 116 shares of Guardant Health, Inc. on February 20, 2025, at a price of $48.33 per share.

Director Tariq Musa reports the acquisition and disposal of Guardant Health, Inc. stock and restricted stock units on February 15, 2025.

Director Myrtle S. Potter reports the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.

Meghan V. Joyce, a director at Guardant Health, Inc., executed stock options on February 4, 2025.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the acquisition and disposal of common stock related to performance-based restricted stock units.

Michael Bell, CFO of Guardant Health, reports the vesting of performance-based restricted stock units and subsequent stock transactions to cover tax obligations.

Director Steve Krognes reported the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.

A director of Guardant Health, Tariq Musa, sold 116 shares of common stock at a price of $37.58 per share on January 17, 2025.

Director Tariq Musa exercised stock options for 250 shares of Guardant Health common stock on January 15, 2025.

Myrtle S. Potter, a director at Guardant Health, Inc., has reported the vesting of 68 restricted stock units.

Terilyn J. Monroe, Chief People Officer at Guardant Health, reports stock transactions including the vesting of restricted stock units and shares withheld for tax obligations.

Guardant Health's Chief Financial Officer, Michael Bell, executed stock transactions involving the vesting of restricted stock units and the sale of shares to cover tax obligations.

Director Meghan Joyce of Guardant Health, Inc. reported the vesting of 66 restricted stock units on January 4, 2025.